For research use only. Not for therapeutic Use.
<span style="color:#000000;"><span style="font-size:12px;"><span style="font-family: Arial, Helvetica, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">3-Hydroxyglutaric acid (CAS 638-18-6) is a glutaric acid derivative which is the byproduct of glutaric acidemia type I. Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in infancy by an acute encephalopathic crisis and often results in permanent motor handicap. Studies indicate that 3-hydroxyglutaric acid can be used as biomarker for GCDH (glutaryl-CoA dehydrogenase) deficiency. </span></span></span>
Catalog Number | R007668 |
CAS Number | 638-18-6 |
Synonyms | 3-Hydroxy-pentanedioic Acid; 2,4-Dideoxypentaric Acid; β-Hydroxyglutaric Acid; |
Molecular Formula | C5H8O5 |
Purity | ≥95% |
Target | Endogenous Metabolite |
Storage | -20°C |
IUPAC Name | 3-hydroxypentanedioic acid |
InChI | InChI=1S/C5H8O5/c6-3(1-4(7)8)2-5(9)10/h3,6H,1-2H2,(H,7,8)(H,9,10) |
InChIKey | ZQHYXNSQOIDNTL-UHFFFAOYSA-N |
SMILES | C(C(CC(=O)O)O)C(=O)O |
Reference | <span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">1.<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">Goodman, Stephen I., et al. "Glutaryl‐CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations." </span><i style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Human mutation</i><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;"> 12.3 (1998): 141-144.<br /> |